← Back to Search

Myo-inositol, folic acid for Gestational diabetes

N/A
Waitlist Available
Led By Amy M Valent, DO
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1,4,7,10
Awards & highlights
No Placebo-Only Group

Summary

Myo-inositol has been shown to decrease the rate of diabetes in pregnancy in European studies. It is not known exactly how this occurs or what it does to the sugar when the supplement is taken. This study purpose is to look at the patient's sugar levels while taking the supplement to see if the overall levels of sugar go down. We hypothesize that in addition to sugar levels, other hormones influencing diabetes will be altered.

Eligible Conditions
  • Gestational diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1,4,7,10
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1,4,7,10 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
overall mean glucose
Secondary study objectives
metabolic differences
Other study objectives
side effects
steady state

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Myo-inositol, folic acidExperimental Treatment3 Interventions
1. myo-inositol, oral, 2g, two times per day for 5 total days 2. folic acid, oral 200 micrograms, two times per day for 7 days 3. Continuous Glucose Monitoring Surveillance device for 7 days during study period 4. Capillary glucose monitoring 4 times per day
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Glucose monitoring
2019
N/A
~10
myo-inositol
2010
Completed Phase 3
~310

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
1,003 Previous Clinical Trials
7,412,350 Total Patients Enrolled
Duke UniversityOTHER
2,451 Previous Clinical Trials
2,971,719 Total Patients Enrolled
Washington University School of MedicineOTHER
1,987 Previous Clinical Trials
2,291,539 Total Patients Enrolled
~4 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top